A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding.
about
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted TherapyNew concepts for an old problem: the diagnosis of endometrial hyperplasiaResearch funding for addressing tobacco-related disease: an analysis of UK investment between 2008 and 2012Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.Years of life lost as a measure of cancer burden on a national levelThe health economics of bladder cancer: an updated review of the published literature.Are the Norwegian health research investments in line with the disease burden?Using Health Care Utilization and Publication Patterns to Characterize the Research Portfolio and to Plan Future Research Investments.The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model.An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values.Years of Life Lost and Childhood and Adolescent Cancer Mortality in Yazd Province, Iran (2004-2009).The gap in digestive organ cancers in Inner Mongolia, 2009-2012Research output and the public health burden of cancer: is there any relationship?Limited Funds for Bladder Cancer Research and What Can We Do About It.The Burden of Road Traffic Injuries in Yazd Province - Iran.Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer.The future of bladder cancer care in the USA.The cost of premature cancer-related mortality: a review and assessment of the evidence.Targeted therapies in bladder cancer: an overview of in vivo research.Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014.FXR-Gankyrin axis is involved in development of pediatric liver cancer.Eclipsed by the Prostate: Expanding Testicular Cancer Scholarship Through Years of Potential Life Lost and Economic Productivity.Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: A cross-sectional study.Assembling and validating data from multiple sources to study care for Veterans with bladder cancer.Bladder Cancer Recovery Pathways: A Systematic Review.Wide-ranging impacts reported by NZ cancer survivors: is supporting cancer survivor resilience a health sector role?Philanthropic partnerships and the future of cancer research.Mortality Rate and Years of Life Lost Due to Prostate Cancer in Yazd Province, Iran: A 10-year study.Inversed relationship between completeness of follow-up and coverage of postoperative complications in gallstone surgery and ERCP: a potential source of bias in patient registers.Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer.Justifiability and Animal Research in Health: Can Democratisation Help Resolve Difficulties?Toward optimal implementation of cancer prevention and control programs in public health: a study protocol on mis-implementation.DNA methylation in urothelial carcinoma.Discrepancies between Canadian cancer research funding and site-specific cancer burden: a spotlight on ten disease sites
P2860
Q21131727-A3BEBB68-437A-4E10-B72F-E0743DC87F21Q28071864-AD660776-C747-46C3-947F-7D35213134A3Q28596195-F6F8D155-9D6C-4DEB-9FED-D12331AC3F23Q30491468-88A94E3D-63EA-4CB8-8835-768C590ED337Q34113539-C8B99516-6D19-480D-A58E-20C9649E9A9EQ34430559-5F2DC7C7-72C5-49B6-9890-26B743238678Q34636332-A3B89BAD-2847-4E5F-9B75-33FD1E79C6FFQ34673111-C0A48FC7-A3D6-49E6-B007-257B2D50DDFFQ36220159-94F9AB45-649F-4ACA-8828-8ABE0710273AQ36238146-154D4147-12D4-44F5-AD07-EFB1B7DD6E82Q36397078-689EFA65-83E0-4E5A-8263-9056807C12A9Q36713138-963C1FB8-8926-4760-8E74-7FABEC5B9A0AQ36807924-EB9CF568-FA20-4082-921C-8E23E188E70BQ37053980-95755934-42F8-48CB-9820-55ABA8B293CEQ37427750-0F424175-0191-4934-996C-698641FBF998Q37587622-8320F835-82E4-41E1-A543-E76C5A63674DQ38131725-BE1D9FB0-E74E-4016-A9EF-154EFF0C4BA1Q38205587-E60E2055-2B6F-45B8-B548-6BE6D7E3001BQ38590471-20A9ED53-F8D3-4619-A48B-23DCB54227BCQ38620198-4CACAF01-C345-482F-BE68-04CDA8A04D32Q38768973-AF56FAD8-08DE-4951-9292-398CFC4853D5Q38803268-0140232F-B57F-4623-8986-4AC1BF3F3D63Q40638271-B5CA21CE-D99C-443E-96FC-6140E617DE3DQ41624975-494E07EA-CD59-48E5-BA72-87FCB181D42AQ45934647-C5FF7F74-6B1A-4308-8B19-CBF67D8E85B8Q47631989-A4C5597E-DF1C-4F54-9ECB-813345A3B217Q48057379-CB921467-4B34-4C7F-BC48-2B49D55F5AE5Q49360753-229150CA-3EF1-4EBA-8E08-2D9DFD5BCA9CQ49398168-D96133BB-6FAF-45EB-9542-78C5C7184F85Q49788912-41881F85-638C-4FD9-AA94-BF4451C5CF0CQ50002245-DDE96CBA-3851-435F-8CC6-826037816BE8Q51736518-47BD5F58-533D-4321-8C39-5C1E8F91EF34Q53691833-0232967B-7AC6-45FC-8346-61FCF96070F9Q59135388-1526FA03-5522-4F38-B372-D55AE5710B0D
P2860
A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A comparison of cancer burden ...... tribution of research funding.
@ast
A comparison of cancer burden ...... tribution of research funding.
@en
A comparison of cancer burden ...... tribution of research funding.
@nl
type
label
A comparison of cancer burden ...... tribution of research funding.
@ast
A comparison of cancer burden ...... tribution of research funding.
@en
A comparison of cancer burden ...... tribution of research funding.
@nl
prefLabel
A comparison of cancer burden ...... tribution of research funding.
@ast
A comparison of cancer burden ...... tribution of research funding.
@en
A comparison of cancer burden ...... tribution of research funding.
@nl
P2860
P356
P1433
P1476
A comparison of cancer burden ...... tribution of research funding.
@en
P2093
Ashley J R Carter
Cecine N Nguyen
P2860
P2888
P356
10.1186/1471-2458-12-526
P407
P577
2012-07-17T00:00:00Z
P5875
P6179
1022701219